Isoniazid Preventive Therapy Completion in the Era of Differentiated HIV Care.
作者信息
Tram Khai Hoan, Mwangwa Florence, Atukunda Mucunguzi, Owaraganise Asiphas, Ayieko James, Plenty Albert, Kwariisima Dalsone, Clark Tamara D, Petersen Maya L, Charlebois Edwin D, Kamya Moses R, Chamie Gabriel, Havlir Diane V, Marquez Carina
机构信息
*Stanford University School of Medicine, Stanford, CA †Infectious Diseases Research Collaboration, Kampala, Uganda ‡Kenya Medical Research Institute, Nairobi, Kenya §Center for AIDS Prevention Studies, University of California, San Francisco, San Francisco, CA ‖Makerere University Joint AIDS Program, Kampala, Uganda ¶Makerere University College of Health Sciences, School of Medicine, Kampala, Uganda #University of California, Berkeley School of Public Health, Berkeley, CA.
出版信息
J Acquir Immune Defic Syndr. 2017 Dec 15;76(5):e115-e117. doi: 10.1097/QAI.0000000000001540.
Abstract
摘要
相似文献
1
Isoniazid Preventive Therapy Completion in the Era of Differentiated HIV Care.差异化HIV照护时代的异烟肼预防性治疗完成情况
J Acquir Immune Defic Syndr. 2017 Dec 15;76(5):e115-e117. doi: 10.1097/QAI.0000000000001540.
2
"It's about my life": facilitators of and barriers to isoniazid preventive therapy completion among people living with HIV in rural South Africa.“关乎我的生活”：南非农村地区艾滋病毒感染者中异烟肼预防性治疗完成的促进因素和障碍
AIDS Care. 2017 Jul;29(7):936-942. doi: 10.1080/09540121.2017.1283390. Epub 2017 Feb 1.
3
Isoniazid preventive therapy for HIV-infected people: evidence to support implementation.针对HIV感染者的异烟肼预防性治疗：支持实施的证据
AIDS. 2010 Nov;24 Suppl 5:S1-3. doi: 10.1097/01.aids.0000391009.95149.ec.
4
Predictors of isoniazid preventive therapy completion among HIV-infected patients receiving differentiated and non-differentiated HIV care in rural Uganda.乌干达农村地区接受差异化和非差异化HIV治疗的HIV感染患者中异烟肼预防性治疗完成情况的预测因素
AIDS Care. 2020 Jan;32(1):119-127. doi: 10.1080/09540121.2019.1619661. Epub 2019 Jun 10.
5
Empirical tuberculosis therapy versus isoniazid in adult outpatients with advanced HIV initiating antiretroviral therapy (REMEMBER): a multicountry open-label randomised controlled trial.成人晚期HIV患者启动抗逆转录病毒治疗时经验性抗结核治疗与异烟肼治疗的比较（REMEMBER）：一项多国开放标签随机对照试验
Lancet. 2016 Mar 19;387(10024):1198-209. doi: 10.1016/S0140-6736(16)00546-8.
6
Preventive therapy against tuberculosis in people living with HIV.针对艾滋病毒感染者的结核病预防性治疗。
Wkly Epidemiol Rec. 1999 Nov 19;74(46):385-98.
7
Outcomes of isoniazid preventive therapy among people living with HIV in Kenya: A retrospective study of routine health care data.肯尼亚艾滋病毒感染者中异烟肼预防性治疗的结局：基于常规医疗保健数据的回顾性研究。
PLoS One. 2020 Dec 2;15(12):e0234588. doi: 10.1371/journal.pone.0234588. eCollection 2020.
8
Implementation of isoniazid preventive therapy for HIV-infected adults: overstatement of district reports.对感染艾滋病毒的成年人实施异烟肼预防性治疗：地区报告夸大情况。
Int J Tuberc Lung Dis. 2014 Aug;18(8):1005. doi: 10.5588/ijtld.13.0855.
9
Isoniazid prophylaxis against tuberculosis in children.儿童结核病的异烟肼预防治疗
N Engl J Med. 2011 Oct 20;365(16):1543; author reply 1543-4. doi: 10.1056/NEJMc1109603.
10
Questions about a placebo-controlled trial of preventive therapy for tuberculosis in HIV-infected Ugandans.关于乌干达感染艾滋病毒人群结核病预防性治疗的安慰剂对照试验的问题。
N Engl J Med. 1998 Mar 19;338(12):841; author reply 842-3. doi: 10.1056/NEJM199803193381214.
引用本文的文献
1
Differentiated HIV Service Delivery vs Conventional Care: Tuberculosis Preventive Therapy Outcomes for People Living with HIV in Sub-Saharan Africa.差异化的艾滋病毒服务提供与传统护理：撒哈拉以南非洲地区艾滋病毒感染者的结核病预防性治疗结果
medRxiv. 2025 Jan 15:2025.01.15.25320590. doi: 10.1101/2025.01.15.25320590.
2
Low completion rate for the 6-months course of isoniazid preventive therapy among people living with HIV, North Eastern Uganda, 2015-2017.2015-2017 年，乌干达东北部艾滋病毒感染者六个月异烟肼预防性治疗课程完成率低。
Pan Afr Med J. 2024 Jul 19;48:122. doi: 10.11604/pamj.2024.48.122.36745. eCollection 2024.
3
Isoniazid preventive therapy completion and factors associated with non-completion among patients on antiretroviral therapy at Kisenyi Health Centre IV, Kampala, Uganda.乌干达坎帕拉基森耶卫生中心 IV 区抗逆转录病毒治疗患者中异烟肼预防性治疗完成情况及与未完成治疗相关的因素。
PLoS One. 2023 Aug 22;18(8):e0277739. doi: 10.1371/journal.pone.0277739. eCollection 2023.
4
Cost-effectiveness of scaling up short course preventive therapy for tuberculosis among children across 12 countries.12个国家扩大儿童结核病短程预防治疗的成本效益
EClinicalMedicine. 2021 Jan 7;31:100707. doi: 10.1016/j.eclinm.2020.100707. eCollection 2021 Jan.
5
A prospective cohort study of outcomes for isoniazid prevention therapy: a nested study from a national QI collaborative in Uganda.异烟肼预防性治疗结局的前瞻性队列研究：乌干达一项全国性质量改进协作项目中的嵌套研究
AIDS Res Ther. 2020 May 27;17(1):28. doi: 10.1186/s12981-020-00285-0.
6
Determinants of isoniazid preventive therapy completion among people living with HIV attending care and treatment clinics from 2013 to 2017 in Dar es Salaam Region, Tanzania. A cross-sectional analytical study.坦桑尼亚达累斯萨拉姆地区 2013 年至 2017 年间，接受护理和治疗诊所服务的艾滋病毒感染者中异烟肼预防性治疗完成情况的决定因素。一项横断面分析研究。
BMC Infect Dis. 2020 Apr 10;20(1):276. doi: 10.1186/s12879-020-04997-6.
7
Predictors of isoniazid preventive therapy completion among HIV-infected patients receiving differentiated and non-differentiated HIV care in rural Uganda.乌干达农村地区接受差异化和非差异化HIV治疗的HIV感染患者中异烟肼预防性治疗完成情况的预测因素
AIDS Care. 2020 Jan;32(1):119-127. doi: 10.1080/09540121.2019.1619661. Epub 2019 Jun 10.
本文引用的文献
1
High rates of viral suppression in adults and children with high CD4+ counts using a streamlined ART delivery model in the SEARCH trial in rural Uganda and Kenya.在乌干达农村和肯尼亚开展的SEARCH试验中，采用简化抗逆转录病毒治疗交付模式，使CD4+计数较高的成人和儿童实现了高病毒抑制率。
J Int AIDS Soc. 2017 Jul 21;20(Suppl 4):21673. doi: 10.7448/IAS.20.5.21673.
2
"It's about my life": facilitators of and barriers to isoniazid preventive therapy completion among people living with HIV in rural South Africa.“关乎我的生活”：南非农村地区艾滋病毒感染者中异烟肼预防性治疗完成的促进因素和障碍
AIDS Care. 2017 Jul;29(7):936-942. doi: 10.1080/09540121.2017.1283390. Epub 2017 Feb 1.
3
Population levels and geographical distribution of HIV RNA in rural Ugandan and Kenyan communities, including serodiscordant couples: a cross-sectional analysis.乌干达和肯尼亚农村社区 HIV RNA 流行水平和地理分布，包括血清不一致的夫妇：一项横断面分析。
Lancet HIV. 2017 Mar;4(3):e122-e133. doi: 10.1016/S2352-3018(16)30220-X. Epub 2016 Dec 16.
4
Predictors of adherence to isoniazid preventive therapy in people living with HIV in Ethiopia.埃塞俄比亚艾滋病毒感染者中异烟肼预防性治疗依从性的预测因素
Int J Tuberc Lung Dis. 2016 Oct;20(10):1342-1347. doi: 10.5588/ijtld.15.0805.
5
A hybrid mobile approach for population-wide HIV testing in rural east Africa: an observational study.在东非农村地区进行全民艾滋病毒检测的混合移动方法：一项观察性研究。
Lancet HIV. 2016 Mar;3(3):e111-9. doi: 10.1016/S2352-3018(15)00251-9. Epub 2016 Jan 26.
6
Implementation and Operational Research: Declining Tuberculosis Incidence Among People Receiving HIV Care and Treatment Services in East Africa, 2007-2012.实施与运营研究：2007 - 2012年东非接受艾滋病毒护理和治疗服务人群中结核病发病率的下降情况
J Acquir Immune Defic Syndr. 2016 Apr 1;71(4):e96-e106. doi: 10.1097/QAI.0000000000000896.
7
High completion of isoniazid preventive therapy among HIV-infected children and adults in Kinshasa, Democratic Republic of Congo.刚果民主共和国金沙萨地区感染艾滋病毒的儿童和成人中异烟肼预防性治疗的高完成率。
AIDS. 2015 Sep 24;29(15):2055-7. doi: 10.1097/QAD.0000000000000791.
8
Acceptability and adherence to Isoniazid preventive therapy in HIV-infected patients clinically screened for latent tuberculosis in Dar es Salaam, Tanzania.坦桑尼亚达累斯萨拉姆对临床上筛查潜伏性结核的艾滋病毒感染患者进行异烟肼预防性治疗的可接受性和依从性。
BMC Infect Dis. 2015 Aug 26;15:368. doi: 10.1186/s12879-015-1085-7.
9
Use of isoniazid preventive therapy for tuberculosis prophylaxis among people living with HIV/AIDS: a review of the literature.在艾滋病毒/艾滋病感染者中使用异烟肼预防性治疗预防结核病：文献综述
J Acquir Immune Defic Syndr. 2015 Apr 15;68 Suppl 3(Suppl 3):S297-305. doi: 10.1097/QAI.0000000000000497.
10
Improved survival and antiretroviral treatment outcomes in adults receiving community-based adherence support: 5-year results from a multicentre cohort study in South Africa.接受社区为基础的依从性支持的成年人的生存和抗逆转录病毒治疗结果得到改善：南非多中心队列研究的 5 年结果。
J Acquir Immune Defic Syndr. 2012 Dec 1;61(4):e50-8. doi: 10.1097/QAI.0b013e31826a6aee.
Zotero 插件